Venture Capital Due Diligence: What Happens After the Verbal “Yes”?

Post-term sheet diligence is when the real work begins. For entrepreneurs, it’s about managing momentum while under a microscope. For medtech investors, it’s about confirming the deal’s risk profile—beyond the pitch deck. “You can’t be surprised with the capital markets where they are,” said Usen. “Sometimes ‘yes’ can turn out to be a really dangerous process if you go on with the wrong partner.”

Originally published at: https://www.lsieuropesummit.com/news/venture-capital-due-diligence-what-happens-after-the-verbal-yes



 

Comments

Post a Comment

Popular posts from this blog

Consumerization of Healthcare: Understanding Patient Behavior

The consumerization of healthcare is reshaping how patients interact with the medical system. As more people take a proactive approach to managing their health, medtech companies have a unique opportunity to harness patient behavior and drive real value. At LSI Europe ’24, a panel of industry experts gathered to discuss the evolving landscape of consumerization in medtech and the need to understand and target patient behaviors to enhance health outcomes. Visit here: https://www.flipgorilla.com/p/29362908924216102/show
Read more

The Global Stage for Live-Saving Innovation

Image
To date, LSI has hosted nine global summits — six in Southern California, three across Europe — and has welcomed more than 10,000 global executives. Too many events are light on real investors. That’s why we’ve built deep, lasting relationships with active VCs, PEs, and CVCs. and create an experience they show up for, year after year. We’re continuing to push the bar by bringing bold ideas and new capital into medtech. This year, we are thrilled to have Harry Stebbings, Founder of 20VC, join us to discuss lessons from the best founders, the AI landscape, and its impact on healthcare. Visit us here for more details:  https://www.lsieuropesummit.com/
Read more